Esther Shohami

Author PubWeight™ 72.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 2006 1.95
2 Mouse closed head injury model induced by a weight-drop device. Nat Protoc 2009 1.66
3 Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol Med 2008 1.63
4 Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev 2002 1.61
5 Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 2004 1.59
6 Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci U S A 2004 1.50
7 low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 2007 1.45
8 Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma 2002 1.40
9 Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J Neurotrauma 2008 1.33
10 Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 2002 1.26
11 Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J Neurotrauma 2005 1.25
12 CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. J Cereb Blood Flow Metab 2005 1.25
13 Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 2005 1.24
14 Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci U S A 2002 1.23
15 Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J 2009 1.23
16 Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 2006 1.22
17 D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. FASEB J 2007 1.20
18 Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab 2010 1.19
19 The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2005 1.19
20 Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol Cell Neurosci 2006 1.12
21 Neurodegeneration induces upregulation of Beclin 1. Autophagy 2006 1.09
22 Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab 2002 1.07
23 Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2003 1.07
24 Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A 2005 1.04
25 The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 2007 1.04
26 Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab 2005 1.01
27 Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 2006 1.01
28 Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J Cereb Blood Flow Metab 2009 1.00
29 Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J 2008 0.99
30 Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 2012 0.98
31 Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury. Glia 2008 0.98
32 Akt phosphorylation is required for heat acclimation-induced neuroprotection. J Neurochem 2007 0.98
33 Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. J Cereb Blood Flow Metab 2008 0.96
34 Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced neuroprotection. J Cereb Blood Flow Metab 2013 0.96
35 N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis. J Cereb Blood Flow Metab 2011 0.95
36 Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J Neurotrauma 2008 0.95
37 Therapeutic vaccination for closed head injury. J Neurotrauma 2003 0.95
38 CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. J Bone Miner Res 2011 0.94
39 N-Acyl amino acids and their impact on biological processes. Biofactors 2014 0.93
40 Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med 2011 0.93
41 Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol Pharmacol 2007 0.93
42 D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window. Eur J Pharmacol 2009 0.91
43 CD38 facilitates recovery from traumatic brain injury. J Neurotrauma 2009 0.90
44 Microglial involvement in neuroprotection following experimental traumatic brain injury in heat-acclimated mice. Brain Res 2008 0.90
45 Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury. J Neurotrauma 2008 0.89
46 Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp Neurol 2005 0.88
47 CuZn-SOD deficiency, rather than overexpression, is associated with enhanced recovery and attenuated activation of NF-kappaB after brain trauma in mice. J Cereb Blood Flow Metab 2006 0.88
48 Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. J Neuroinflammation 2004 0.84
49 Altered cytokine expression and sustained hypothermia following traumatic brain injury in heat acclimated mice. Brain Res 2007 0.84
50 N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury. J Cereb Blood Flow Metab 2013 0.83
51 Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2. Acta Neuropathol 2001 0.83
52 The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Curr Alzheimer Res 2005 0.82
53 Regional sensitivity to neuroinflammation: in vivo and in vitro studies. Synapse 2011 0.82
54 Heat acclimation: a unique model of physiologically mediated global preconditioning against traumatic brain injury. Prog Brain Res 2007 0.82
55 Novel approach to the role of NMDA receptors in traumatic brain injury. CNS Neurol Disord Drug Targets 2014 0.81
56 The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. J Neurotrauma 2011 0.81
57 Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice. J Neurotrauma 2012 0.81
58 Brain trauma induces X-box protein 1 processing indicative of activation of the endoplasmic reticulum unfolded protein response. J Neurochem 2004 0.81
59 Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury. Neurotherapeutics 2014 0.80
60 Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury. J Neurotrauma 2014 0.79
61 Impairment of the ability of the injured aged brain in elevating urate and ascorbate. Exp Gerontol 2006 0.79
62 Protective effects of incensole acetate on cerebral ischemic injury. Brain Res 2012 0.79
63 A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. J Mol Neurosci 2002 0.78
64 The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. Neuroreport 2002 0.78
65 Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults. Neuroreport 2003 0.78
66 Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury. J Mol Neurosci 2012 0.78
67 Ouabain improves functional recovery following traumatic brain injury. J Neurotrauma 2014 0.77
68 The role and dynamics of β-catenin in precondition induced neuroprotection after traumatic brain injury. PLoS One 2013 0.76
69 Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. J Neuroimmune Pharmacol 2015 0.76
70 Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury? J Basic Clin Physiol Pharmacol 2016 0.76
71 Brain injury-dependent expression of activity-dependent neuroprotective protein. J Mol Neurosci 2004 0.76
72 The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Peptides 2005 0.75
73 Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J Cereb Blood Flow Metab 2015 0.75
74 Astaxanthin, a Potential Preconditioned Neuroprotective Agent to Traumatic Brain Injury: 255 Board #92 June 1, 9: 30 AM - 11: 00 AM. Med Sci Sports Exerc 2016 0.75
75 Cannabinoids in Health and Disease. J Basic Clin Physiol Pharmacol 2016 0.75
76 Synergism between tumor necrosis factor-alpha and H2O2 enhances cell damage in rat PC12 cells. Neurosci Lett 2003 0.75
77 Neuroprotective effects of the Ras inhibitor S-trans-trans-farnesylthiosalicylic acid, measured by diffusion-weighted imaging after traumatic brain injury in rats. J Neurotrauma 2007 0.75